RHOADS ANN D

Director · QDEL, GMED, RPTX, ITOS

As of 2026-09-16, RHOADS ANN D has 35 Form 4 transactions on record across 4 companies — 17 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $4KIndirect: $0$4Kas of 2026-09-16
  • Direct $4K
  • Indirect $0
QDELdirect369 sh$4K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

QDEL · 23 trades
2026-06-25: Award / grant, 15,532 sh ($0)2026-06-25: Award / grant, 369 sh ($0)2026-06-25: Award / grant, 3,698 sh ($0)2026-05-29: Award / grant, 6,829 sh ($0)2026-05-29: Option exercise, 6,829 sh ($0)2026-05-22: Award / grant, 234 sh ($0)2026-05-22: Option exercise, 234 sh ($0)2026-05-22: Option exercise, 1,173 sh ($0)2026-05-22: Award / grant, 1,173 sh ($0)2025-12-10: Purchase, 750 sh ($21K)2025-05-29: Award / grant, 6,829 sh ($0)2025-05-29: Award / grant, 325 sh ($0)2025-05-29: Award / grant, 1,626 sh ($0)2025-05-24: Award / grant, 109 sh ($0)2025-05-24: Option exercise, 109 sh ($0)2025-05-24: Option exercise, 546 sh ($0)2025-05-24: Award / grant, 546 sh ($0)2025-05-22: Option exercise, 4,929 sh ($0)2025-05-22: Award / grant, 4,929 sh ($0)2025-05-18: Option exercise, 128 sh ($0)2025-05-18: Award / grant, 128 sh ($0)2025-05-18: Award / grant, 427 sh ($0)2025-05-18: Option exercise, 427 sh ($0)
GMED · 8 trades
2026-06-04: Option exercise, 25,000 sh ($657K)2026-06-04: Option exercise, 25,000 sh ($0)2026-01-21: Award / grant, 15,000 sh ($0)2025-11-10: Sale, 2,000 sh ($170K)2025-11-07: Sale, 8,000 sh ($648K)2025-09-15: Sale, 10,000 sh ($585K)2025-02-28: Sale, 7,500 sh ($590K)2025-01-23: Award / grant, 15,000 sh ($0)
RPTX · 2 trades
2026-01-28: Disposition, 4,000 sh2026-01-28: Disposition, 4,000 sh
ITOS · 2 trades
2025-08-29: Disposition, 27,178 sh2025-08-29: Disposition, 27,178 sh

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2025-12-10QDELPurchase750 @ $28.27$21K+5.3% of holding15,021Form 4
2025-11-10GMEDSale2,000 @ $85.00$170K−11.5% of holding15,384Form 4
2025-11-07GMEDSale8,000 @ $81.00$648K−31.5% of holding17,384Form 4
2025-09-15GMEDSale10,000 @ $58.46$585K−28.3% of holding25,384Form 4
2025-02-28GMEDSale7,500 @ $78.68$590K−17.5% of holding35,384Form 4
30 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-06-25QDELAward / grant15,53215,532Form 4
2026-06-25QDELAward / grant369369Form 4
2026-06-25QDELAward / grant3,6983,698Form 4
2026-06-04GMEDOption exercise25,00040,384Form 4
2026-06-04GMEDOption exercise25,0000Form 4
2026-05-29QDELAward / grant6,82923,257Form 4
2026-05-29QDELOption exercise6,8290Form 4
2026-05-22QDELAward / grant23416,428Form 4
2026-05-22QDELOption exercise2340Form 4
2026-05-22QDELOption exercise1,1730Form 4
2026-05-22QDELAward / grant1,17316,194Form 4
2026-01-28RPTXDisposition4,0000Form 4
2026-01-28RPTXDisposition4,0000Form 4
2026-01-21GMEDAward / grant15,00015,000Form 4
2025-08-29ITOSDisposition27,1780Form 4
2025-08-29ITOSDisposition27,1780Form 4
2025-05-29QDELAward / grant6,8296,829Form 4
2025-05-29QDELAward / grant325325Form 4
2025-05-29QDELAward / grant1,6261,626Form 4
2025-05-24QDELAward / grant10914,271Form 4
2025-05-24QDELOption exercise1090Form 4
2025-05-24QDELOption exercise5460Form 4
2025-05-24QDELAward / grant54614,162Form 4
2025-05-22QDELOption exercise4,9290Form 4
2025-05-22QDELAward / grant4,92913,616Form 4
2025-05-18QDELOption exercise1280Form 4
2025-05-18QDELAward / grant1288,687Form 4
2025-05-18QDELAward / grant4278,559Form 4
2025-05-18QDELOption exercise4270Form 4
2025-01-23GMEDAward / grant15,00015,000Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.